Screening costs in a hepatitis B vaccine program
West, K.H.; Yuras, R.J.
Jems a Journal of Emergency Medical Services 15(8): 40-43
1990
ISSN/ISBN: 0197-2510 PMID: 10105760 Document Number: 357680
Current statistics from the Centers for Disease Control (CDC) reveal that approximately 39 percent of all fire/rescue personnel have been vaccinated against hepatitis B. Iti well-documented that hepatitis B viral infection presents the greatest occupational health risk to emergency personnel, yet program development and care-provider participation have been slow to evolve.
Document emailed within 1 workday
Related Documents
Jerome, D.; Laurent, C.; Catherine, B.; Didier, S.; Bertrand, C.; Muriel, R.; Joseph, M.; Olivier, Z.; Thiery, P.; Claude, C.J.an 2002: Costs of hospital management of hepatitis C virus cirrhosis in France Comparison between real costs and diagnosis related groups based costs Results of a multicentric study carried out on 267 consecutive patients in 1998 Hepatology 36(4 Part 2): 587AYuan, C.D. 1989: Immune response and reactions to simultaneous administration of hepatitis B vaccine with routine vaccine in children. II. Immune response and reactions to simultaneous administration of hepatitis B vaccine with Japanese B encephalitis vaccine and measles vaccine Zhonghua Liu Xing Bing Xue Za Zhi 10(4): 210-214
Su, S-Yung. 2019: The impact of national viral hepatitis therapy program and hepatitis B vaccination program on mortality from acute and chronic viral hepatitis in Taiwan Hepatology International 13(2): 157-164
Akamatsu, N.; Ide, M.; Ueda, Y.; Kondo, Y.; Nakamura, S.; Mori, T.; Ogimoto, I.; Yoshimura, T. 1986: A population survey on mass screening program for gastric cancer part 1. population characteristics related to examination rates for screening program Journal of UOEH 8(2): 177-184
Stevens, C.E.; Taylor, P.E.; Tong, M.J.; Toy, P.T.; Vyas, G.N.; Nair, P.V.; Weissman, J.Y.; Krugman, S. 1987: Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission JAMA 257(19): 2612-2616
Townsend, J.S.; Steele, C.Brooke.; Hayes, N.; Bhatt, A.; Moore, A.R. 2017: Human Papillomavirus Vaccine as an Anticancer Vaccine: Collaborative Efforts to Promote Human Papillomavirus Vaccine in the National Comprehensive Cancer Control Program Journal of Women's Health 26(3): 200-206
Bravo, L.; Carlos, J.; Gatchalian, S.; Borja-Tabora, C.; Bibera, G.; Willems, P.; Safary, A.; Bock, H.L. 1998: The new DTPw-HBV-Hib combination vaccine can be used at the who schedule with a monovalent dose of hepatitis B vaccine at birth Southeast Asian Journal of Tropical Medicine and Public Health 29(4): 772-778
Akahane, Y. 1981: Development of research on B-type hepatitis virus vaccine---including HBs antigen polypeptide vaccine Nihon Rinsho. Japanese Journal of Clinical Medicine 39(3): 619-630
Faingezicht, I.; Avila-Aguerro, M.L.; Cervantes, Y.; Fourneau, M.; Clemens, S.A.C. 2002: Primary and booster vaccination with DTPw-HB/Hib pentavalent vaccine in Costa Rican children who had received a birth dose of hepatitis B vaccine Revista Panamericana de Salud Publica 12(4): 247-257
Hu, Z.; Teng, H.; Han, M. 1994: Observation on prevention of hepatitis B virus transmission from mother to baby by hepatitis B vaccine Zhonghua Liu Xing Bing Xue Za Zhi 15(6): 346-348
Curciarello, J.O.; Corallini, O.; Adrover, R.E.; Chiera, A.O.; Giammona, A.M.; Barbero, R.; Apraiz, M.; Belloni, P.O.; Neumann, M.; Jmelnitzky, A.C. 1994: Viral hepatitis infection and response to the hepatitis B vaccine in hemodialyzed patients Acta Gastroenterologica Latinoamericana 25(5): 291-296
Inskip, H.M.; Hall, A.J.; Temple, I.K.; Loik, F.; Herbage, E.; Chotard, J.; Whittle, H. 1991: Response to hepatitis B vaccine in relation to the hepatitis B status of family members International Journal of Epidemiology 20(3): 770-773
McIntyre, A.; Nimmo, G.R.; Wood, G.M.; Tinniswood, R.D.; Kerlin, P. 1992: Isolated hepatitis B core antibody--can response to hepatitis B vaccine help elucidate the cause? Australian and New Zealand Journal of Medicine 22(1): 19-22
Liu, K.Z. 1989: A preliminary study on response to hepatitis B vaccine in subjects with various levels of antibody to hepatitis B surface antigen Zhonghua Yu Fang Yi Xue Za Zhi 23(3): 132-134
Shahzad, A.; Köhler, G. 2009: Inactivated Polio Vaccine (IPV): a strong candidate vaccine for achieving global polio eradication program Vaccine 27(39): 5293-5294
Levy, H.L.; Madigan, P.M.; Shih, V.E. 1972: Massachusetts metabolic disorders screening program. I. Technics and results of urine screening Pediatrics 49(6): 825-836
Sporea, I.; Popescu, A. 2014: No colorectal cancer screening program in Romania! Thus, start with opportunistic screening Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 118(3): 598-600
Ciatto, S.; Rosselli Del Turco, M. 1991: Rates of recall for thorough examination and surgical biopsy following mammographic screening. Experience with the screening program in Florence La Radiologia Medica 82(1-2): 56-59
Trehu, E.G.; Cooper, J.N. 1992: Cost of screening for colorectal cancer: results of a community mass screening program and review of the literature Southern Medical Journal 85(3): 248-254
Bat, L.; Pines, A.; Ron, E.; Niv, Y.; Arditi, E.; Shemesh, E. 1986: A community-based program of colorectal screening in an asymptomatic population: evaluation of screening tests and compliance American Journal of Gastroenterology 81(8): 647-651